Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04776096
Status:
COMPLETED
Last Update Posted:
2022-12-15
First Post:
2021-02-25
Brief Title:
Efficacy and Toxicity of Bepotastine 15 PF vs Olopatadine 02 With BAK on Allergic Conjunctivitis Treatment
Sponsor:
Laboratorios Poen
Organization:
Laboratorios Poen
Organization Data
Organization:
Laboratorios Poen
Class:
INDUSTRY
Study ID:
ANTILERG001-19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Laboratorios Poen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None